1-10 of 10
Edith P. Mitchell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT160: BVD-523FB (Ulixertinib) in Patients with Tumors with BRAF Fusions, or with Non-V600E, Non-V600K BRAF Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol EAY131-Z1L

Vivek Subbiah, Fengmin Fengmin, Ragini Kudchadkar, Ryan J. Sullivan, Edith P. Mitchell, John J. Wright, Helen X. Chen, Robert J. Gray, Xin Victoria Wang, Lisa M. McShane, Larry V. Rubinstein, David Patton, P. Mickey Williams, Tilak K. Sundaresan, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT160.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT160
Published: 15 June 2022
View article
Journal Articles

Abstract 2624: Clinical trial participation in real-world patients with metastatic breast cancer: disparities and barriers

Ruoding Tan, Rongrong Wang, Ibrahim Abbass, Lourenia Cassoli, Edith P. Mitchell
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2624.
DOI: https://doi.org/10.1158/1538-7445.AM2021-2624
Published: 01 July 2021
View article
Journal Articles

Abstract PS7-53: Assessing racial differences in patients with metastatic triple-negative breast cancer: Real-world evidence from US community oncology practices

Amie Tan, Vincent Shen, Luciana Preger, Bann-mo Day, Edith P. Mitchell
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS7-53.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS7-53
Published: 15 February 2021
View article
Journal Articles

Abstract CT061: Binimetinib in patients with tumors with NRAS mutations: NCI-MATCH ECOG-ACRIN Cancer Research Group subprotocol EAY131-Z1A

James M. Cleary, Victoria Wang, Rebecca Heist, Scott Kopetz, Edith P. Mitchell, James Zwiebel, Helen X. Chen, Shuli Li, Robert Gray, Lisa McShane, Larry Rubinstein, David Patton, Funda Meric-Bernstam, Melissa Dillmon, Mickey Williams, Stanley Hamilton, Barbara Conley, Peter O'Dwyer, Lyndsay Harris, Carlos Arteaga, Alice Chen, Keith Flaherty
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT061.
DOI: https://doi.org/10.1158/1538-7445.AM2020-CT061
Published: 15 August 2020
View article
Journal Articles

Abstract CT139: NCI Molecular Analysis for Therapy Choice (NCI-MATCH EAY131) arm B: Phase II study of afatinib in patients (pts) with HER2 (ERBB2) activating mutations

Philippe L. Bedard, Shuli Li, Kari B. Wisinski, Eddy S. Yang, Sewanti A. Limaye, Edith P. Mitchell, James A. Zwiebel, Jeffrey Moscow, Robert J. Gray, Lisa M. McShane, Larry V. Rubenstein, David R. Patton, P Mickey Williams, Stanley R. Hamilton, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT139.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT139
Published: 01 July 2019
View article
Journal Articles

Abstract CT138: NCI-MATCH EAY131 -Z1I: Phase II study of AZD1775, a wee-1 kinase inhibitor, in patients with tumors containing BRCA1 and BRCA2 mutations

Shivaani Kummar, Shuli Li, Kim Reiss, James M. Ford, Edith P. Mitchell, James A. Zwiebel, Naoko Takebe, Robert J. Gray, Lisa M. McShane, Larry V. Rubinstein, David Patton, Paul Mickey Williams, Stanley R. Hamilton, Adam Brufsky, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT138.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT138
Published: 01 July 2019
View article
Journal Articles

Abstract LB-010: Molecular analysis for therapy choice (NCI-MATCH, EAY131) arm Z1B: Phase II trial of palbociclib for CCND1, 2 or 3 amplified tumors

Amy S. Clark, Fangxin Hong, Richard S. Finn, Angela M. DeMichele, Edith P. Mitchell, James Zweibel, Fernanda I. Arnaldez, Lisa M. McShane, Shuli Li, Robert J. Gray, Larry V. Rubenstein, David Patton, P Mickey Williams, Stanley R. Hamilton, Mehmet S. Copur, Sameer S. Kasbari, Ravneet Thind, Barbara A. Conley, Peter J. O'Dwyer, Lyndsay N. Harris, Carlos L. Arteaga, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-010.
DOI: https://doi.org/10.1158/1538-7445.AM2019-LB-010
Published: 01 July 2019
View article
Journal Articles

Abstract 2257: Phase II study of dual immune checkpoint blockade (ICB) with durvalumab (Durva) plus tremelimumab (T) following palliative hypofractionated radiotherapy (SBRT) in patients (pts) with microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) progressing on chemotherapy: NSABP FC-9

James J. Lee, Greg Yothers, Thomas J. George, Marwan G. Fakih, Atrayee Basu Mallick, Edith P. Mitchell, James L. Wade, John C. Krauss, Omar R. Kayaleh, Dwight E. Heron, Carmen J. Allegra, Corey Lipchik, Huichen Feng, Marion Joy, Ashok Srinivasan, Katherine L. Pogue-Geile, Peter C. Lucas, Sarah E. Warren, Alessandra Cesano, Samuel A. Jacobs
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2257.
DOI: https://doi.org/10.1158/1538-7445.AM2019-2257
Published: 01 July 2019
View article
Journal Articles

Abstract B98: Final results of a randomized phase Ib study of fractionated 90Y-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having at least two prior therapies

Vincent J. Picozzi, Ramesh K. Ramanathan, Maeve A. Lowery, Allyson J. Ocean, Edith P. Mitchell, Bert H. O'Neil, Michael J. Guarino, Paul R. Conkling, Steven J. Cohen, Nathan Bahary, Richard C. Frank, Tomislav Dragovich, Benjamin B. Bridges, Marie Lee, Ronald L. Korn, Neeta Pandit-Taskar, Stanley J. Goldsmith, Charles M. Intenzo, Arif Sheikh, Timothy C. Manzone, Michael L. Miller, Michael Yu, Judith M. Joyce, Edward B. Strauss, Susan Passalaqua, Ronald V. Dorn, III, Michael J. Anderson, Michael Holt, Fadi S. Braiteh, Fa-Chyi Lee, Thomas E. Gribbin, Donald A. Richards, Alexander N. Starodub, Wegener A. William, Eileen M. O'Reilly, Daniel D. Von Hoff, David M. Goldenberg
Journal: Cancer Research
Cancer Res (2015) 75 (13_Supplement): B98.
DOI: https://doi.org/10.1158/1538-7445.PANCA2014-B98
Published: 30 June 2015
View article
Journal Articles

Cardiotoxicity of Epirubicin and Doxorubicin: Assessment by Endomyocardial Biopsy

Frank M. Torti, Michael M. Bristow, Bert L. Lum, Stephen K. Carter, Anthony E. Howes, Diana A. Aston, Byron W. Brown, Jr., John F. Hannigan, Jr., Frederick J. Meyers, Edith P. Mitchell, Margaret E. Billingham
Journal: Cancer Research
Cancer Res (1986) 46 (7): 3722–3727.
Published: 01 July 1986
View article
PDF